Clinical Trial Update: Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated Voluven for its effects on hemodynamics and tolerability of enteral nutrition in patients with severe sepsis, with results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Voluven (hydroxyethyl starch 130/0.4)

Snippet

Sponsor: Fresenius Kabi | Conditions: Sepsis | Phase 3 | Status: COMPLETED | Results posted: 2011-08-02